Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Here are 10 stores where you can get a free Thanksgiving turkey - 2Astronauts' brains change shape and position after time in space, study finds
- 3Students were skipping my astrophysics class to play video games – so I turned the class itself into a video game
- 4Former elite Australian soldier charged with Afghan war crimes
- 5‘I love this work, but it’s killing me’: The unique toll of being a spiritual leader today
- Revealing the Specialty of Food Matching: Improving Culinary Encounters
- The moon up close: How the Artemis 2 astronauts are photographing their historic lunar flyby
- Figurine of a woman and a goose offers peek at prehistoric beliefs
- Heat Wave Fuels Massive Wildfire In Australia
- Influencers are selling a delusional fantasy of being postpartum. Why is it so easy to believe?
- 'Tangled' live-action movie casts Teagan Croft and Milo Manheim as Rapunzel and Flynn
- The Solution to Innovative Peculiarity: Analyzing the Fate of Mankind
- 'Euphoria' releases Season 3 photos with Zendaya, Sydney Sweeney, Jacob Elordi and others: See them
- Check out the exclusive pitch deck Valerie Health used to raise $30 million from Redpoint Ventures to automate healthcare faxes
